A molecular 'signature' of primary breast cancer cultures; patterns resembling tumor tissue

BackgroundTo identify the spectrum of malignant attributes maintained outside the host environment, we have compared global gene expression in primary breast tumors and matched short-term epithelial cultures.ResultsIn contrast to immortal cell lines, a characteristic 'limited proliferation' phenotype was observed, which included over expressed genes associated with the TGFβ signal transduction pathway, such as SPARC, LOXL1, RUNX1, and DAPK1. Underlying this profile was the conspicuous absence of hTERT expression and telomerase activity, a significant increase in TβRII, its cognate ligand, and the CDK inhibitor, p21CIP1/WAF1. Concurrently, tumor tissue and primary cultures displayed low transcript levels of proliferation-related genes, such as, TOP2A, ANKT, RAD51, UBE2C, CENPA, RRM2, and PLK.ConclusionsOur data demonstrate that commonly used immortal cell lines do not reflect some aspects of tumor biology as closely as primary tumor cell cultures. The gene expression profile of malignant tissue, which is uniquely retained by cells cultured on solid substrates, could facilitate the development and testing of novel molecular targets for breast cancer.

[1]  A. Balmain,et al.  TGF-beta signaling in tumor suppression and cancer progression. , 2001, Nature genetics.

[2]  P. Brown,et al.  A DNA microarray system for analyzing complex DNA samples using two-color fluorescent probe hybridization. , 1996, Genome research.

[3]  M. Westerfield,et al.  Characterization of paired tumor and non‐tumor cell lines established from patients with breast cancer , 1998, International journal of cancer.

[4]  M. Brattain,et al.  Transforming growth factor beta 1 increases the stability of p21/WAF1/CIP1 protein and inhibits CDK2 kinase activity in human colon carcinoma FET cells. , 2003, Cancer research.

[5]  R. Jove,et al.  Role of epidermal growth factor receptor and STAT-3 activation in autonomous proliferation of SUM-102PT human breast cancer cells. , 1997, Cancer research.

[6]  A. Thor,et al.  p21WAF1/CIP1 Expression in breast cancers: associations with p53 and outcome , 2000, Breast Cancer Research and Treatment.

[7]  S. Dairkee,et al.  Propagation of genetically altered tumor cells derived from fine-needle aspirates of primary breast carcinoma. , 1998, Cancer research.

[8]  A. Green,et al.  Short-term primary culture of epithelial cells derived from human breast tumours. , 1998, British Journal of Cancer.

[9]  M. Ashburner,et al.  Gene Ontology: tool for the unification of biology , 2000, Nature Genetics.

[10]  S. Dairkee,et al.  Partial enzymatic degradation of stroma allows enrichment and expansion of primary breast tumor cells. , 1997, Cancer research.

[11]  O. Petersen,et al.  Differential tumorigenicity of two autologous human breast carcinoma cell lines, HMT-3909S1 and HMT-3909S8, established in serum-free medium. , 1990, Cancer research.

[12]  T. Hastie,et al.  Optimization and evaluation of T7 based RNA linear amplification protocols for cDNA microarray analysis , 2002, BMC Genomics.

[13]  B. Weber,et al.  Differential isolation of normal luminal mammary epithelial cells and breast cancer cells from primary and metastatic sites using selective media. , 1993, Cancer research.

[14]  J. Gutiérrez,et al.  Mechanical stretch modulates TGF-β1 and α1(I) collagen expression in fetal human intestinal smooth muscle cells. , 1999, American journal of physiology. Gastrointestinal and liver physiology.

[15]  D. Fournier,et al.  Growth rate of 147 mammary carcinomas , 1980, Cancer.

[16]  S. Dairkee,et al.  Selective cell culture of primary breast carcinoma. , 1995, Cancer research.

[17]  M. Bissell,et al.  Interaction with basement membrane serves to rapidly distinguish growth and differentiation pattern of normal and malignant human breast epithelial cells. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[18]  P. Yaswen,et al.  Molecular changes accompanying senescence and immortalization of cultured human mammary epithelial cells. , 2002, The international journal of biochemistry & cell biology.

[19]  Xiao-Fan Wang,et al.  Transforming growth factor beta induces the cyclin-dependent kinase inhibitor p21 through a p53-independent mechanism. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[20]  M. Kallassy,et al.  Growth arrest of immortalized human keratinocytes and suppression of telomerase activity by p21WAF1 gene expression , 1998, Molecular carcinogenesis.

[21]  Christian A. Rees,et al.  Systematic variation in gene expression patterns in human cancer cell lines , 2000, Nature Genetics.

[22]  Yudong D. He,et al.  Gene expression profiling predicts clinical outcome of breast cancer , 2002, Nature.

[23]  R. Tibshirani,et al.  Significance analysis of microarrays applied to the ionizing radiation response , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[24]  S. Dairkee,et al.  Genome-wide allelotyping of a new in vitro model system reveals early events in breast cancer progression. , 2002, Cancer research.

[25]  D. Botstein,et al.  Cluster analysis and display of genome-wide expression patterns. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[26]  V. Band,et al.  Distinctive traits of normal and tumor-derived human mammary epithelial cells expressed in a medium that supports long-term growth of both cell types. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[27]  J. Minna,et al.  Comparison of features of human breast cancer cell lines and their corresponding tumors. , 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.

[28]  M. Sporn,et al.  Characterization of the promoter region of the human transforming growth factor-beta 1 gene. , 1989, The Journal of biological chemistry.

[29]  C F Dewey,et al.  Platelet-derived growth factor B chain promoter contains a cis-acting fluid shear-stress-responsive element. , 1993, Proceedings of the National Academy of Sciences of the United States of America.